Evidence for the interaction between antacid and gastric mucosa using an "artificial stomach" model including gastric mucosa.

In light of evidence that certain aluminum-based antacids adhere to the gastric mucosa, we modified our previously described "artificial stomach" (AS) model by including a piece of hog stomach and compared the antacid activity of six aluminum-containing antacid products in the model with and without gastric mucosa. The activity of three of these, Maalox, Riopan and Supralox, was not significantly different in the two systems. In contrast, the activity of the other three, Aludrox, Phosphalugel and Simeco, was significantly greater with mucosa. Antacid activity of one product from each set (Supralox, Phosphalugel) was evaluated in two in vivo methods in human volunteers. For both antacids, results in vivo were similar to those obtained with the AS-containing mucosa. Without mucosa, in vivo and in vitro results were dissimilar for Phosphalugel, thus validating the modified AS. The difference between the two sets of antacids can be explained by 1) the fact that the Al:Mg ratio in the set affected by mucosa is greater than that of unaffected antacids, and 2) a weaker antacid load than in unaffected Supralox. We suggest that in an acid milieu, aluminum ions in antacids like Aludrox, Phosphalugel and Simeco are bound to sialic acid residues in mucus glycoproteins, thus retarding the transit of these antacids through both the AS and the real stomach and prolonging their activity in both situations. When the Al:Mg ratio is low or when the amount of antacid salts is large, aluminum ions tend to be buried in complexes, giving them less chance to interact with gastric mucus, so they transit the stomach more quickly.     

Molecular genetic characterization of XRCC4 function

XRCC4 is a generally expressed protein of 334 amino acids that is involved in the repair of DNA double-strand breaks and in V(D)J recombination, but its function is unknown. In this study, we have used a mutational approach and the yeast two-hybrid method to perform an initial characterization of this protein. We show that the XRCC4 protein is located in the nucleus. We also demonstrate that several potential phosphorylation sites are not required for XRCC4 function in a transient V(D)J recombination assay. In addition, we show that XRCC4 forms a homodimer in vivo with the homodimerization domain being located within amino acids 115-204. Finally, we define a core domain of XRCC4 that functions in V(D)J recombination and comprises amino acids 18-204. Potential functions of XRCC4 are discussed.      

扫描电镜图像处理系统及其在细胞超微结构定量计算中的应用

本文介绍一种具有较高性能价格比的生物医学电镜图像处理系统,该系统以IBM PC/XT,AT或386计算机为主机,图像接口板直接插入机内扩展槽。应用软件可对生物医学图像作图像处理和定量计算。作者通过对人膈腹膜超微结构进行定量分析,为腹水的治疗和腹膜透析(CAPD)等临床医学研究,提供了形态学定量资料。     

磁刺激用平面线圈结构的优化研究

文中建立了采用任意形状平面线圈磁刺激仪的RLC模型，给出了模型参数的计算方法。为了优化线圈，将磁刺激仪线圈的性能指标分为反映线圈输出性能的峰值磁能和反映线圈结构的几何变量。在磁刺激激活函数达到阈值条件下，调整平面螺旋线圈的结构并计算出依赖于线圈结构参数的输出性能值，从而，寻找最优的线圈几何参数。优化结果表明：线圈外半径是关键因素，给定阈值条件，选择合适的线圈外半径，可以大大降低线圈峰值磁能；另外，现在使用的圆环线圈并非最优，D形线圈优于圆环线圈。     

中药灵芝对健康人甲襞微循环的作用

系统观察５７例健康人口服灵芝（灵芝多糖体５５ｍｇ／片）前后甲襞微循环的变化。结果显示：服药前后大、小动脉血压无显著变化；口服灵芝３天后输入枝口径及输出枝口径均有明显扩张；管袢密度、红细胞流速增加不显著。口服灵芝７天的动态变化显示，服药８ｈ后输入枝、输出枝口径即有显著扩张，第７天管袢密度开始明显增加。服用不同剂量灵芝（２片、４片、８片，３次／日）３ｈ后，管袢密度、输入枝、输出枝口径、流速均有增加趋向，但Ｐ＞０．０５，其中８片组管袢口径、管袢密度有显著增加（Ｐ＜０．０５），但红细胞流速却有显著下降（Ｐ＜０．０５）。结果提示：连续、适量（２片，３次～４次／日）服用灵芝，可显著改善微循环灌流量，从而改善和保护组织及脏器功能。     

抗人喉癌/抗VEGF双功能抗体制备及应用研究

目的：研制抗人喉癌／抗血管内皮因子（VEGF）双功能克隆抗体，用于喉癌抗血管生成治疗。方法：采用二次杂交瘤技术制备抗人喉癌／抗VEGF双功能抗体。经酶联免疫吸附试验法和SP法检测喉癌及癌前病患者血清及癌组织中VEGF的含量表达。结果：获得6株分泌抗人喉癌／抗VEGF双功能抗体的杂交瘤，经免疫组化证实与喉癌细胞特异性结合率为93％，而与血管内皮细胞结合率为89％。血清中VEGF含量表达，喉癌组与癌前病组及正常对照组相比差异均显著。IgG亚型鉴定为IgG2aBSAb抗体效价为1：25 600倍（ELISA法）。结论：二次杂交瘤法制备的双功能抗体具有均匀性、可控性、效价高、稳定性好，可用于喉癌抗血管生成治疗，动态检测可作为判断喉癌预后的客观指标。     

乙醇对人绒毛孕酮分泌的影响

本工作利用灌流技术观察了四种不同浓度的乙醇(0.5％、1％、2.5％、5％)对妊娠早期人工流产新鲜胎盘绒毛分泌孕酮的影响。结果表明,乙醇具有促进孕酮分泌的作用,并存在剂量依赖的关系。提示乙醇可能破坏胎盘激素内分泌的平衡,从而影响胎儿的正常生长与发育。     

Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis

The primary lesion in rheumatoid arthritis (RA) is a destructive synovitis characterized by proliferation of endothelial cells, fibroblasts, and vascular smooth muscle cells, and with perivascular lymphocyte aggregates. A nonhematopoietic growth factor, acidic fibroblast growth factor (aFGF), may induce many of the biological features found in rheumatoid synovium, including T cell activation. To determine if aFGF-responsive T cells are increased in RA, we developed an assay to measure the frequency of peripheral blood T cells that are costimulated by aFGF. The data indicate that the frequency of aFGF-responsive T cells is increased in RA and may change with disease activity and treatment.